Ohta Masayoshi, Hiramoto Michiaki, Fujii Miki, Togo Takeshi
Department of Plastic and Reconstructive Surgery, Kyoto University Hospital, Kyoto, Japan.
Dermatol Surg. 2004 Sep;30(9):1265-8. doi: 10.1111/j.1524-4725.2004.30390.x.
Nodular hidradenocarcinoma was first reported as clear-cell eccrine carcinoma by Keasby and Hadley in 1954 (Cancer 1954;7:934-52) and rare malignant tumor. Several synonyms and related terms for nodular hidradenocarcinoma have appeared in the literature.
They have potential for uncontrollable local recurrence, tend to metastasize, and often cause death. Most cases have been reported in the pathology literature with limited clinical information.
We report a 27-year-old woman with nodular hidradenocarcinoma on the scalp.
The management of rare cases is not well defined. In our case, she was only treated with a wide local excision, and no recurrence was observed 2 years after excision.
Most authors have concluded that early wide surgical excision of the tumor is the treatment of choice. The efficiency of adjuvant therapy generally has not established.
结节性汗腺癌于1954年由基斯比和哈德利首次报道为透明细胞小汗腺癌（《癌症》1954年；7:934 - 52），是一种罕见的恶性肿瘤。文献中出现了结节性汗腺癌的几个同义词和相关术语。
它们有局部复发难以控制的可能性，易于转移，且常导致死亡。大多数病例在病理文献中报道，临床信息有限。
我们报告一名27岁头皮患有结节性汗腺癌的女性。
罕见病例的治疗方法尚无明确界定。在我们的病例中，她仅接受了广泛局部切除，切除后2年未观察到复发。
大多数作者得出结论，早期广泛手术切除肿瘤是首选治疗方法。辅助治疗的疗效一般尚未确立。
Zotero 插件